DNAprint Genomics (DNAG)

[frogdreaming]

bag8ger, How is it possible for DNAP to keep thing so close to the vest that even the investors can't find out anything, including any scrap of information about the status of Statnome. (i.e. progress, schedule, ETA or potential market), and yet the CEO of Genaissance can not only suss out all of the above, but see that DNAP is ahead of him at every turn? In fact he is able to derive enough information that he can convince his own BOD to write off all the money previously spent and to change course in mid stream.

On the one hand you are congratulating DNAP for clamping down on the information flow to the public and you are spinning it as a positive because it protects the IP....and on the other hand you are suggesting that the competition has a window into the inner workings of the company that is so wide that the things that they see are enough to base huge, paradigm shifting changes to their business plan.

How is it possible to reconcile these conflicting viewpoints?